Michigan Supreme Court Clears Way for Attorney General to Investigate Eli Lilly Over Insulin Pricing.
admin In a landmark 4-to-3 decision that carries significant implications for the pharmaceutical industry’s pricing power,...
Health
The Strategic Imperative of Securing the U.S. Pharmaceutical Supply Chain Against Chinese Industrial Dominance.
In the complex landscape of global health and national security, a vigorous debate has emerged...
The Invisible Scourge: Why Mycetoma Remains the Most Neglected of Tropical Diseases.
When I met Tesfaye at Boru Meda General Hospital in the Amhara region of Ethiopia,...
Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more
On Wednesday, a high-stakes meeting of the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee...
Rising oil prices can boost the cost of some medicines. One expert says it’s time to lower reliance on fossil fuels
In a landmark report released this week, Unitaid, the global health agency hosted by the...
The American Diabetes Association’s Fall from Grace: From Defending Integrity to Policing Speech.
The transformation of the American Diabetes Association (ADA) from a stalwart defender of scientific integrity...
The Regulatory Paradox: How FDA’s Application of Platform Technology Designation Is Stalling Rare Disease Breakthroughs.
When Kat Bryant Knudson was first diagnosed with limb girdle muscular dystrophy (LGMD), she was...
Correcting the Record on COVID-19 Interventions and the Path Forward for Public Health Research
The discourse surrounding the efficacy of nonpharmaceutical interventions (NPIs) during the COVID-19 pandemic remains one...
Health Policy Shift: Senate Advances Key Nominees, Courts Uphold Medicaid Mandates, and the Looming Threat of Infectious Diseases.
The American healthcare landscape is currently navigating a period of profound transition as the federal...
Novo Nordisk’s Ziltivekimab Fails to Reduce Heart Risks in Major Trial, Casting Doubt on Inflammation Hypothesis.
The pharmaceutical landscape shifted dramatically on Friday as Novo Nordisk, the Danish powerhouse currently dominating...
